CC003 / Chupu Chuang (Wuhan) Pharmaceutical Technology - LARVOL DELTA

Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003. (PubMed, J Clin Oncol) - "Although the study did not meet its primary end point of DR preservation, HA during PCI reduces the risk of overall neurocognitive toxicity with noninferior ICR risk and similar survival."

Journal • P2/3 data • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor